Ionis Pharmaceuticals, Inc.
MODULATORS OF FOXP3 EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting FOXP3 expression, which may be useful for treating, preventing, or ameliorating cancer.
Status:
Application
Type:
Utility
Filling date:
14 Nov 2019
Issue date:
11 Jun 2020